ISRG stock $525.81 pre-market 26 Jan 2026 NASDAQ: Model shows 15.25% upside
ISRG stock trades at $525.81 pre-market on NASDAQ in the United States on 26 Jan 2026 as investors weigh valuation against continued procedure growth. The company reports EPS $7.89 and a PE of 66.41 while market cap stands at $187.84B. Volume is 2,911,800 shares versus an average of 2,198,114. As an AI stocks play, Intuitive Surgical’s robotics and connected platforms keep it relevant to algorithmic and clinical workflows. Meyka AI provides real-time, AI-powered market analysis to frame the near-term outlook.
ISRG stock snapshot and market pulse
ISRG stock opened at $525.41 and shows intraday range $522.72–$532.00. The 50-day average is $563.47 and the 200-day average is $515.36, indicating recent underperformance versus near-term momentum. Year range is $425.00–$609.08.
Trading volume at 2,911,800 is above average, reflecting active positioning ahead of the next earnings cycle. The stock trades on NASDAQ in the United States and remains widely held by growth and healthcare portfolios.
ISRG stock: earnings, growth and financials
Intuitive Surgical reports EPS of $7.89 and strong margin metrics with net profit margin near 28.38%. Trailing revenue per share is $28.36 and free cash flow per share is $6.40. FY 2024 revenue growth was 17.24% and free cash flow grew 73.93%, showing operational leverage.
The balance sheet shows $13.83 cash per share and no long-term debt. Investors should weigh robust cash generation and R&D spend of 13.03% of revenue against a high valuation.
ISRG stock technicals and trading signals
Momentum indicators favor bulls but show caution. RSI is 65.69 and MACD histogram is 0.11, signaling moderate upside without clear breakout. ATR is 11.47, so expect daily swings near that range.
On-chain technicals: OBV sits at 24,818,529 and the stock shows a relative strength that has returned 104.70% over three years. Traders should monitor the $542.28 Bollinger lower band and the $566.22 middle band for support and resistance cues.
ISRG stock valuation and risk factors
Valuation remains premium. Price to sales is 18.66, price to book is 10.98, and price to free cash flow is 82.69. Those ratios reflect AI-enabled growth expectations priced into shares.
Risks include procedure volume sensitivity, hospital capital cycles, and regulatory or reimbursement changes. A high PE of 66.41 amplifies downside if growth slows. Inventory days are lengthy at 190.40, which can affect working capital in downturns.
ISRG stock: analyst consensus and Meyka rating
Analyst mix leans positive with 17 Buys, 4 Holds, 2 Sells in the latest consensus. Recent headlines and coverage are tracked on major outlets such as CNBC and MarketBeat.
Meyka AI rates ISRG with a score out of 100: 74.57 | Grade: B+ | Suggestion: BUY. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecast models. These grades are not guarantees and we are not financial advisors.
ISRG stock and the AI-enabled surgical opportunity
Intuitive Surgical sits at the intersection of robotics and applied clinical AI. The Ion system and digital services expand addressable markets beyond operating rooms. Hospitals adopting program-level analytics can drive recurring instrument and service revenue.
Investors focused on AI stocks should watch adoption curves, software monetization, and data-driven procedure efficiency metrics. For a deep company overview visit Meyka’s ISRG page for live signals and model updates: Meyka ISRG page.
Final Thoughts
Key takeaways on ISRG stock: price is $525.81 pre-market on NASDAQ in the United States and the business shows durable cash conversion and margin strength. Meyka AI’s forecast model projects a yearly price of $605.93 USD, implying an upside of 15.25% versus the current price. Shorter-term forecasts include monthly $504.41 and quarterly $508.28, reflecting possible near-term consolidation. Valuation is rich with PE at 66.41 and price-to-sales near 18.66, which requires sustained top-line momentum to justify the premium. Analysts remain broadly positive with 17 Buys in consensus, yet elevated ratios increase volatility risk. For AI stocks allocations, ISRG blends exposure to robotic automation and clinical AI, but investors should size positions to reflect valuation risk and monitor the upcoming earnings announcement on 2026-04-21. Forecasts are model-based projections and not guarantees.
FAQs
What is the current price of ISRG stock and where does it trade?
ISRG stock is trading at $525.81 pre-market on NASDAQ in the United States. Market cap is $187.84B and average volume is 2,198,114 shares, reflecting active institutional interest and retail liquidity.
What does Meyka AI forecast for ISRG stock?
Meyka AI’s forecast model projects a yearly price of $605.93 USD, implying about 15.25% upside from $525.81. These model projections are analytical estimates and not guarantees.
How do fundamentals support ISRG stock valuation?
Intuitive delivers high margins and cash flow with EPS $7.89 and free cash flow per share $6.40. However, premium multiples like PE 66.41 and P/S 18.66 require continued revenue growth to justify valuation.
What are the main risks for ISRG stock investors?
Risks include procedure volume cycles, hospital capital spending pauses, regulatory shifts, and premium valuation. Inventory days at 190.40 and a high P/FCF ratio increase sensitivity to slower growth.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
